Royal Biologics Debuts Advanced Bone Grafting, Fusion Kit

Royal Biologics has launched its advanced fusion bone grafting system, Advanced – Cell in the United States. Advanced – Cell combines multiple autologous and advanced bone grafting technologies in one convenience kit. 

Advanced – Cell enables users to provide an optimal live cellular grafting option, combined with next-generation bone grafting technology to deliver point of care in a low-cost bundle option. Operating room times, supply chains and cost savings are now streamlined when providing multiple advanced grafting options in one packaged kit. 

“We are very excited to launch Advanced-Cell to our portfolio of Advanced Cellular Technologies & Enhancing Autologous Healing options in the U.S.,” said Salvatore Leo, CEO and founder of Royal Biologics. “Advanced-Cell provides multiple bone grafting and enhanced autologous healing options for point of care use in orthopedics. Additionally, by bundling these three technologies into one convenience kit, we can help streamline supply chain disruptions, reduce time in the operating rooms and provide increased value in a low-cost option product matrix. With increased lead times in supply chains and shortages in global resources, we see a tremendous value in offering a product with multiple grafting options, all in one kit and point of care.” 
 
Advanced – Cell offers three different technologies that promote and support the key components for bone fusion and enhanced autologous healing.
 
Maxx-Cell has created a new gold standard in bone marrow aspiration therapy for various uses in orthopedics, sports medicine and pain management. It delivers the highest, most pure enriched form of bone marrow aspirate without the need for centrifugation, according to the company. It also maximizes cell count yields and CFUs while minimizing peripheral blood dilution. Stem cells and Mesenchymal cells are now easily and effectively obtained with this device. Data supports that obtaining fresh aspirate collections from multiple locations inside of bone provides optimal colony-forming unit samples. Maxx-Cell combined with various bone grafting options creates an advanced live cellular graft to be used point of care in multiple specialty settings.  
 
Bio-Reign Bioactive Matrix is a next-generation, advanced synthetic osteoconductive porous implant that supports an ideal environment for bone growth. Bio-Reign provides an optimal trio blend of components that include bioactive glass, carbon apatite anorganic bone mineral and type 1 collagen. This unique particle blend provides a superior  bone graft substitute option for orthopedic fusion procedures. 
 
Royal Autograft Harvesting System – An additional gold standard autograft technology, the autograft harvesting system provides an optimal 8 gauge trephine to provide users the ability percutaneously harvest cancellous bone, point of care. Harvesting intact bone cores exploits the biology of normal fracture healing versus incorporation of non-vascularized grafts. 
 
Advanced – Cell is the latest addition to Royal Biologics’ portfolio of Advanced Cellular Technologies & Enhanced Autologous Healing solutions.